Cervical cancer is as a kind of cancer beginning from the cervix. Given that cervical cancer
could be observed in women who infected with papillomavirus, regular oral contraceptives …

Cervical cancer is the fourth leading cause of cancer-related death among women
worldwide. The chemotherapeutical agent cisplatin, a small platinum-based compound, is …

As one of the commonest gynecological malignancies in the world, cervical cancer brings
great threat for public health. Long non-coding RNAs (LncRNAs) have been proved to be …

Long non-coding RNA HOTAIR has been revealed to participate in the tumorigenesis of
various cancers. However, the mechanism of HOTAIR involvement in cervical cancer has …

Recent studies have showed that microRNA-150 (miR-150) is up-regulated in various
cancers including cervical cancer. However, the specific mechanism of miR-150 in the …

Sema4C, the target of many miRNAs, is involved in EMT-mediated chemotherapeutic
resistance of many malignant tumors. However, the underlying upstream regulatory …

Cervical cancer is one of the most common gynecological malignancies in women
worldwide. The long non-coding RNA (lncRNA) LINC00473 is increased in some human …

Brachytherapy has advanced dramatically in the last decade due largely to improvements in
applicators, imaging, treatment planning, and use of clinical trials. In addition, current …

Although a potentially preventable disease, cervical cancer (CC) is the second most
commonly diagnosed gynaecological cancer with at least 530,000 new cases annually, and …

Introduction Lymphoma is a common canine cancer with translational relevance to human
disease. Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype, contributing …